Aggregated
No track record data- Bullish
- 8
- Hold
- 0
- Bearish
- 0
RBC Capital
An RBC Capital analyst with 34 tracked ratings across 14 distinct tickers holds a 2.2 out of 5 stars track record, with a 62.5% success rate on the captured sample.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| MGTX | 2026-05-15 | buy | $25.00 | Aggregated |
| EYPT | 2026-05-07 | buy | $37.00 | Aggregated |
| FDMT | 2026-05-07 | buy | $35.00 | Aggregated |
| MIRM | 2026-05-07 | buy | $142.00 | Aggregated |
| UTHR | 2026-05-07 | buy | $701.00 | Aggregated |
| OCUL | 2026-05-06 | buy | $30.00 | Aggregated |
| RYTM | 2026-05-06 | buy | $137.00 | Aggregated |
| UTHR | 2026-05-06 | buy | $701.00 | Aggregated |
| VRDN | 2026-05-06 | buy | $34.00 | Aggregated |
| OCUL | 2026-05-05 | buy | $30.00 | Aggregated |
| RYTM | 2026-05-05 | buy | $137.00 | Aggregated |
| MGTX | 2026-04-17 | buy | $24.00 | Aggregated |
| VRDN | 2026-04-07 | buy | $30.00 | Aggregated |
| FDMT | 2026-03-19 | buy | $35.00 | Aggregated |
| RYTM | 2026-03-17 | buy | $130.00 | Aggregated |
| VRDN | 2026-02-27 | buy | $42.00 | Aggregated |
| APLS | 2026-02-25 | unknown | $21.00 | Aggregated |
| RYTM | 2026-02-19 | buy | $145.00 | Aggregated |
| MGTX | 2025-11-14 | buy | $16.00 | Aggregated |
| FDMT | 2025-11-11 | buy | $32.00 | Aggregated |
| FDMT4D MOLECULAR THERAPEUTICS INC | 2025-11-11 | unknown | $32.00 | Aggregated |
| EYPT | 2025-11-06 | buy | $39.00 | Aggregated |
| EYPTEYEPOINT PHARMACEUTICALS INC | 2025-11-06 | unknown | $39.00 | Aggregated |
| VRDN | 2025-11-06 | buy | $45.00 | Aggregated |
| VRDNVIRIDIAN THERAPEUTICS INC | 2025-11-06 | unknown | $45.00 | Aggregated |
| UTHRUNITED THERAPEUTICS CORP | 2025-10-30 | unknown | $587.00 | Aggregated |
| ADVMADVERUM BIOTECHNOLOGIES INC | 2025-10-28 | unknown | $4.00 | Aggregated |
| FDMT | 2025-10-21 | buy | $26.00 | Aggregated |
| VRDN | 2025-08-07 | buy | $41.00 | Aggregated |
| APLS | 2025-08-01 | unknown | $19.00 | Aggregated |
| EYPT | 2025-06-17 | buy | $28.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| MGTX | 3 | 2026-05-15 | Aggregated |
| EYPT | 3 | 2026-05-07 | Aggregated |
| FDMT | 4 | 2026-05-07 | Aggregated |
| MIRM | 2 | 2026-05-07 | Aggregated |
| UTHR | 3 | 2026-05-07 | Aggregated |
| OCUL | 2 | 2026-05-06 | Aggregated |
| RYTM | 4 | 2026-05-06 | Aggregated |
| VRDN | 7 | 2026-05-06 | Aggregated |
| APLS | 2 | 2026-02-25 | Aggregated |
| FDMT4D MOLECULAR THERAPEUTICS INC | 1 | 2025-11-11 | Aggregated |
| EYPTEYEPOINT PHARMACEUTICALS INC | 1 | 2025-11-06 | Aggregated |
| VRDNVIRIDIAN THERAPEUTICS INC | 1 | 2025-11-06 | Aggregated |
| UTHRUNITED THERAPEUTICS CORP | 1 | 2025-10-30 | Aggregated |
| ADVMADVERUM BIOTECHNOLOGIES INC | 1 | 2025-10-28 | Aggregated |